Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$140.56 USD
-0.87 (-0.62%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $140.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | 0.07 |
Last EPS Surprise | NA |
ABR | 1.32 |
Earnings ESP
|
-135.93% |
---|---|
Current Year | 1.54 |
Next Year | 9.96 |
EPS (TTM) | 0.81 |
P/E (F1) | 91.02 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 417.13M | 572.13M | 1.77B | 3.06B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 504.96M | 648.20M | 1.95B | 3.17B |
Low Estimate | 390.64M | 536.01M | 1.70B | 3.01B |
Year ago Sales | 331.82M | 396.78M | 1.24B | 1.77B |
Year over Year Growth Est. | 25.71% | 44.19% | 42.19% | 73.32% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | 1.26 | 1.54 | 9.96 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | -0.12 | 0.68 | 1.08 | 9.37 |
High Estimate | 0.46 | 1.76 | 1.85 | 13.41 |
Low Estimate | -0.40 | 0.68 | 0.96 | 5.79 |
Year ago EPS | -0.46 | 0.47 | -5.80 | 1.54 |
Year over Year Growth Est. | 86.96% | 168.09% | 126.55% | 546.19% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 4 |
Up Last 60 Days | 1 | 1 | 1 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 6 | 2 |
Down Last 60 Days | 4 | 4 | 6 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | 1.26 | 1.54 | 9.96 |
7 Days Ago | -0.06 | 1.26 | 1.54 | 9.96 |
30 Days Ago | 1.00 | 2.49 | 3.76 | 9.25 |
60 Days Ago | 0.98 | 2.42 | 3.71 | 8.95 |
90 Days Ago | 0.88 | 1.73 | 2.46 | 6.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | 1.33 | 1.51 | 9.96 |
Zacks Consensus Estimate | -0.06 | 1.26 | 1.54 | 9.96 |
Earnings ESP | -135.93% | 5.02% | -2.44% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.07 | 0.73 | 0.47 | -0.46 | NA |
Estimate | 0.00 | -0.11 | -0.03 | -1.66 | NA |
Difference | 0.07 | 0.84 | 0.50 | 1.20 | 0.65 |
Surprise | NA | 763.64% | 1,666.67% | 72.29% | 834.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more